Odyssean »

NBT Ban shares owned by Odyssean

Quarter-by-quarter ownership of NBT Ban (NBTB) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in NBT Ban

Tip: Access up to 7 years of quarterly data

All positions including NBT Ban held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in NBT Ban by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $461k 9.3k 49.37

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding NBT Ban

BlackRock
Vanguard Portfolio Management
State Street Corporation
Dimensional Fund Advisors
Vanguard Capital Management
Geode Capital Management
Silvercrest Asset Management Group
Northern Trust
Victory Capital Management
Charles Schwab Investment Management
Manufacturers Life Insurance Company
American Century Companies
Bank of New York Mellon
Morgan Stanley
Raymond James Financial

View all funds holding NBT Ban